News

DiabeCell is Living Cell Technologies’ treatment designed to normalise the lives of people with insulin-dependent diabetes. DiabeCell comprises encapsulated porcine insulin-producing cells (islets) that are implanted into the

Under the terms of the agreement Antares and Uman will invest jointly to develop and commercialize Vibex MTX, Antares’ new pressure-assisted, injection device, containing methotrexate (MTX) for rheumatoid

The investment is part of SAFC’s worldwide facilities initiative and is designed to better serve the biopharmaceutical industry by creating ‘Centers of Excellence’ for manufacturing and supply chain

The project is expected to expand Standard Process’ existing 260,000 square foot headquarters to accommodate additional processing capacity. The expansion is estimated to be completed by October 31,

Reportedly, the approval is based on the on subgroup data from Jupiter study, which evaluated the impact of rosuvastatin 20mg on reducing major cardiovascular events in a previously

Earlier, FDA had granted PrevOnco orphan drug status in August 2008, and in March 2010, additionally, NexMed has filed its investigational new drug (IND) application for the product

As per the agreement, cancer vaccine experts at RUMC are expected to perform exploratory studies on Homspera relating to its adjuvant and immunomodulatory properties for potential application in

Protalix BioTherapeutics said that it has made the submission in response to a request from the FDA for validation data from its upgraded manufacturing facility. The FDA is

Invida is expected to be in charge of filing and commercialising the drugs in different countries. The agreement is for an initial period of five years renewable for